troxipide has been researched along with Brain Neoplasms in 1 studies
troxipide: RN given refers to parent cpd
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, E | 1 |
| Choi, PJ | 1 |
| Schweder, P | 1 |
| Mee, E | 1 |
| Turner, C | 1 |
| Faull, R | 1 |
| Denny, WA | 1 |
| Dragunow, M | 1 |
| I-H Park, T | 1 |
| Jose, J | 1 |
1 other study available for troxipide and Brain Neoplasms
| Article | Year |
|---|---|
Cytoprotective agent troxipide-cyanine dye conjugate with cytotoxic and antiproliferative activity in patient-derived glioblastoma cell lines.
Topics: Antineoplastic Agents; Brain Neoplasms; Carbocyanines; Cell Line, Tumor; Cell Proliferation; Cell Su | 2021 |